1. Home
  2. BBY vs MDGL Comparison

BBY vs MDGL Comparison

Compare BBY & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Best Buy Co. Inc.

BBY

Best Buy Co. Inc.

HOLD

Current Price

$66.76

Market Cap

12.9B

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$520.46

Market Cap

12.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBY
MDGL
Founded
1966
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
12.2B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
BBY
MDGL
Price
$66.76
$520.46
Analyst Decision
Buy
Strong Buy
Analyst Count
19
12
Target Price
$76.28
$674.45
AVG Volume (30 Days)
3.7M
351.2K
Earning Date
05-28-2026
04-28-2026
Dividend Yield
5.74%
N/A
EPS Growth
17.76
41.32
EPS
5.04
N/A
Revenue
$41,691,000,000.00
$180,133,000.00
Revenue This Year
$1.15
$58.39
Revenue Next Year
$1.38
$48.55
P/E Ratio
$13.33
N/A
Revenue Growth
0.39
N/A
52 Week Low
$59.77
$265.00
52 Week High
$84.99
$615.00

Technical Indicators

Market Signals
Indicator
BBY
MDGL
Relative Strength Index (RSI) 63.78 55.63
Support Level $66.21 $503.93
Resistance Level $69.26 $539.17
Average True Range (ATR) 1.87 17.10
MACD 0.53 -1.58
Stochastic Oscillator 98.53 30.14

Price Performance

Historical Comparison
BBY
MDGL

About BBY Best Buy Co. Inc.

With over $41 billion in consolidated 2024 sales, Best Buy is the largest pure-play consumer electronics retailer in the US, boasting roughly 8% share of the North American market and around 33% share of offline sales in the region, per our calculations, CTA, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the covid pandemic, have seen the US e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Share on Social Networks: